微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.56% | -47.76% | -80.84% | 39/159 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 13.36% | -1.33% | 18.02% | 18/159 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 11.32% | -3.74% | 39.58% | 20/159 | 4.18% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 8.11% | -2.76% | 65.51% | 17/159 | 2.63% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 4.9% | -3.73% | -63.81% | 9/159 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 13.54% | 20.04% | 15.14% | 15/159 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 11.76% | 21.61% | 41.01% | 13/159 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 8.34% | 47.35% | 63.85% | 11/159 | 1.47% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 5.09% | 144.71% | -54.88% | 10/159 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 11.28% | 48.42% | 16.65% | 37/159 | 0.74% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 9.67% | 55.47% | 70.85% | 32/159 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 5.66% | 67.95% | 172.12% | 39/159 | 2.22% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 2.08% | 60% | -72.63% | 58/159 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 7.6% | 60.34% | 22.19% | 59/159 | 0.87% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 6.22% | 62.4% | 84.57% | 65/159 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 3.37% | 224.04% | 159.23% | 76/159 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 1.3% | 664.71% | -72.57% | 86/159 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 4.74% | -21.91% | 23.76% | 88/159 | 3.71% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 3.83% | -44.97% | 268.27% | 79/159 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 1.04% | -78.86% | 511.76% | 101/159 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 0.17% | -93.49% | -97.2% | 86/159 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 6.07% | -32.56% | -12.79% | 79/159 | 2.71% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 6.96% | -16.25% | 41.46% | 51/159 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 4.92% | -16.61% | 88.51% | 49/159 | 5.02% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 2.61% | -18.44% | -71% | 41/159 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 9% | 650% | 8.3% | 57/159 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 8.31% | 151.06% | 40.85% | 39/159 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 5.9% | 158.77% | 84.38% | 32/159 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 3.2% | 91.62% | 166.67% | 27/159 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 1.2% | -74.95% | -63.75% | 113/159 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 3.31% | -30.32% | 45.18% | 75/159 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 2.28% | -27.62% | 36.53% | 81/159 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 1.67% | -10.7% | -65.14% | 50/159 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 4.79% | -16.7% | 0.84% | 84/159 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 4.75% | -6.13% | 50.79% | 50/159 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 3.15% | -7.35% | 68.45% | 56/159 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 1.87% | -1.58% | -67.48% | 44/159 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 5.75% | -35.9% | 13.64% | 71/159 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 5.06% | -37.84% | 48.82% | 47/159 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 3.4% | -33.07% | 78.95% | 51/159 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 1.9% | -17.75% | -78.82% | 42/159 | 2.41% | 华东医药 | 26.63% | 行业排名> |